Optimal use of anti-EGFR monoclonal antibodies for patients with advanced colorectal cancer: a meta-analysis
Crossref DOI link: https://doi.org/10.1007/s10555-017-9668-y
Published Online: 2017-07-10
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
van Helden, E. J.
Menke-van der Houven van Oordt, C. W.
Heymans, M. W.
Ket, J. C. F.
van den Oord, R.
Verheul, H. M. W.
Funding for this research was provided by:
KWF Kankerbestrijding (2012-5565)
License valid from 2017-06-01